Longwood Team

Strategic Advisory Board

Lotte Bjerre Knudsen, DMSc

Breakthrough Prize, GLP-1, Lasker Award; Chief Scientific Advisor (former), Novo Nordisk

Jay Bradner, MD

EVP, R&D & CSO, Amgen

Deborah Dunsire, MD

CEO (former), Lundbeck, XTuit, FORUM, Millenium

Victor Dzau, MD

President (former), National Academy of Medicine

Stephen Elledge, PhD

Gregor Mendel Professor of Genetics and of Medicine, Harvard ; Lasker Award-winner, HHMI Co-Founder, TScan

Laurie Glimcher, MD

CEO (former), Dana-Farber Cancer Institute; Harvard

Barry Greene

CEO (former), Sage Therapeutics; President (former), Alnylam

William Hait, MD, PhD

Chief Scientific Advisor, AACR; Global Head (former), Janssen R&D

Peter Hutt, LLB, LLM

General Counsel (former), FDA; SAB: SIRT, Alnara, Vertero BOD: Momenta, Concert Pharmaceuticals, Solu Therapeutics

Anne Klibanski, MD

President & CEO, Mass General Brigham

Sally Kornbluth, PhD

President, MIT

Lou Lange, MD, PhD

Chair & CEO (former), CV Therapeutics (Gilead)

John Maraganore, PhD

CEO (former), Alnylam; Chair (former), BIO

Fiona Marshall, PhD

President, BioMedical Research, Novartis

Stefan Oelrich

CEO, Bayer Pharmaceuticals

Al Sandrock, MD, PhD

CEO, Voyager Therapeutics

Paul Schimmel, PhD

NAS; Scripps; Co-Founder: Alnylam; SAB: Momenta, Sirtris

Phil Sharp, PhD

Nobel Laureate; NAS; Co-Founder: Biogen, Alnylam SAB: Sirtris, Verastem

Christophe Weber

President & CEO (former), Takeda

K. Dane Wittrup, PhD

MIT, Koch; Scientific Co-Founder: Adimab, Immunitas

Kai Wucherpfennig, MD, PhD

Chair, Cancer Immunology & Virology, Dana-Farber Cancer Institute; Harvard, Broad; Scientific Co-Founder: Immunitas; SAB: TScan